Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Mga view
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Magpakita ng higit pa
Mga Komento sa Facebook
Walang nakitang komento